$VSTM Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Verastem, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Verastem, Inc.. Get notifications about new insider transactions in Verastem, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 25 2013 | VSTM | Verastem, Inc. | Westphal Christoph H | Chief Executive Off ... | Buy | L | 9.38 | 100 | 938 | 704,531 | 704.4 K to 704.5 K (+0.01 %) |
Mar 25 2013 | VSTM | Verastem, Inc. | Westphal Christoph H | Chief Executive Off ... | Buy | L | 9.37 | 100 | 937 | 704,431 | 704.3 K to 704.4 K (+0.01 %) |
Mar 25 2013 | VSTM | Verastem, Inc. | Westphal Christoph H | Chief Executive Off ... | Buy | L | 9.32 | 600 | 5,592 | 704,331 | 703.7 K to 704.3 K (+0.09 %) |
Mar 14 2013 | VSTM | Verastem, Inc. | Westphal Christoph H | Chief Executive Off ... | Payment of Exercise | F | 9.37 | 36,864 | 345,416 | 703,731 | 740.6 K to 703.7 K (-4.98 %) |
Mar 14 2013 | VSTM | Verastem, Inc. | Pachter Jonathan | VP, Head of Researc ... | Payment of Exercise | F | 9.37 | 10,074 | 94,393 | 75,640 | 85.7 K to 75.6 K (-11.75 %) |
Mar 14 2013 | VSTM | Verastem, Inc. | Forrester Robert | President and COO | Payment of Exercise | F | 9.37 | 16,883 | 158,194 | 253,974 | 270.9 K to 254 K (-6.23 %) |
Mar 14 2013 | VSTM | Verastem, Inc. | Paterson Dan | Head of Corp. Dev., ... | Payment of Exercise | F | 9.37 | 13,427 | 125,811 | 100,859 | 114.3 K to 100.9 K (-11.75 %) |
Mar 07 2013 | VSTM | Verastem, Inc. | Westphal Christoph H | Chief Executive Off ... | Buy | P | 9.47 | 800 | 7,576 | 740,595 | 739.8 K to 740.6 K (+0.11 %) |
Mar 07 2013 | VSTM | Verastem, Inc. | Westphal Christoph H | Chief Executive Off ... | Buy | L | 9.99 | 200 | 1,998 | 739,795 | 739.6 K to 739.8 K (+0.03 %) |
Mar 07 2013 | VSTM | Verastem, Inc. | Westphal Christoph H | Chief Executive Off ... | Buy | L | 9.98 | 200 | 1,996 | 739,595 | 739.4 K to 739.6 K (+0.03 %) |
Mar 07 2013 | VSTM | Verastem, Inc. | Westphal Christoph H | Chief Executive Off ... | Buy | L | 9.96 | 41 | 408 | 739,395 | 739.4 K to 739.4 K (+0.01 %) |
Mar 07 2013 | VSTM | Verastem, Inc. | Westphal Christoph H | Chief Executive Off ... | Buy | L | 9.95 | 259 | 2,577 | 739,354 | 739.1 K to 739.4 K (+0.04 %) |
Mar 07 2013 | VSTM | Verastem, Inc. | Westphal Christoph H | Chief Executive Off ... | Buy | L | 9.93 | 100 | 993 | 739,095 | 739 K to 739.1 K (+0.01 %) |
Mar 06 2013 | VSTM | Verastem, Inc. | SHERWIN STEPHEN A | Director | Option Exercise | A | 9.23 | 25,000 | 230,750 | 25,000 | |
Feb 14 2013 | VSTM | Verastem, Inc. | Westphal Christoph H | Chief Executive Off ... | Buy | L | 10.00 | 298 | 2,980 | 738,995 | 738.7 K to 739 K (+0.04 %) |
Feb 14 2013 | VSTM | Verastem, Inc. | Westphal Christoph H | Chief Executive Off ... | Buy | L | 9.91 | 98 | 971 | 738,697 | 738.6 K to 738.7 K (+0.01 %) |
Feb 14 2013 | VSTM | Verastem, Inc. | Westphal Christoph H | Chief Executive Off ... | Buy | L | 9.90 | 100 | 990 | 738,599 | 738.5 K to 738.6 K (+0.01 %) |
Feb 14 2013 | VSTM | Verastem, Inc. | Westphal Christoph H | Chief Executive Off ... | Buy | L | 9.87 | 200 | 1,974 | 738,499 | 738.3 K to 738.5 K (+0.03 %) |
Feb 14 2013 | VSTM | Verastem, Inc. | Westphal Christoph H | Chief Executive Off ... | Buy | L | 9.73 | 4 | 39 | 738,299 | 738.3 K to 738.3 K (0.00 %) |
Feb 14 2013 | VSTM | Verastem, Inc. | Westphal Christoph H | Chief Executive Off ... | Buy | L | 9.65 | 100 | 965 | 738,295 | 738.2 K to 738.3 K (+0.01 %) |
Feb 14 2013 | VSTM | Verastem, Inc. | Westphal Christoph H | Chief Executive Off ... | Grant | A | 0.00 | 25,826 | 0 | 738,195 | 712.4 K to 738.2 K (+3.63 %) |
Jan 31 2013 | VSTM | Verastem, Inc. | Westphal Christoph H | Chief Executive Off ... | Buy | P | 10.00 | 300 | 3,000 | 712,369 | 712.1 K to 712.4 K (+0.04 %) |
Jan 31 2013 | VSTM | Verastem, Inc. | Westphal Christoph H | Chief Executive Off ... | Buy | L | 10.00 | 502 | 5,020 | 712,069 | 711.6 K to 712.1 K (+0.07 %) |
Jan 31 2013 | VSTM | Verastem, Inc. | Westphal Christoph H | Chief Executive Off ... | Buy | L | 9.99 | 198 | 1,978 | 711,567 | 711.4 K to 711.6 K (+0.03 %) |
Jan 31 2013 | VSTM | Verastem, Inc. | Westphal Christoph H | Chief Executive Off ... | Buy | L | 9.97 | 100 | 997 | 711,369 | 711.3 K to 711.4 K (+0.01 %) |
Jan 17 2013 | VSTM | Verastem, Inc. | Paterson Dan | Head of Corp. Dev, ... | Option Exercise | A | 9.85 | 80,000 | 788,000 | 80,000 | |
Jan 17 2013 | VSTM | Verastem, Inc. | Pachter Jonathan | VP, Head of Researc ... | Option Exercise | A | 9.85 | 40,000 | 394,000 | 40,000 | |
Jan 17 2013 | VSTM | Verastem, Inc. | Forrester Robert | Chief Operating Off ... | Option Exercise | A | 9.85 | 250,000 | 2,462,500 | 250,000 | |
Jan 03 2013 | VSTM | Verastem, Inc. | Westphal Christoph H | President and C.E.O ... | Buy | P | 9.73 | 800 | 7,784 | 711,269 | 710.5 K to 711.3 K (+0.11 %) |
Jan 03 2013 | VSTM | Verastem, Inc. | Westphal Christoph H | President and C.E.O ... | Buy | L | 8.91 | 476 | 4,241 | 710,469 | 710 K to 710.5 K (+0.07 %) |
Jan 03 2013 | VSTM | Verastem, Inc. | Westphal Christoph H | President and C.E.O ... | Buy | L | 8.87 | 200 | 1,774 | 709,993 | 709.8 K to 710 K (+0.03 %) |
Jan 03 2013 | VSTM | Verastem, Inc. | Westphal Christoph H | President and C.E.O ... | Buy | L | 8.79 | 100 | 879 | 709,793 | 709.7 K to 709.8 K (+0.01 %) |
Jan 03 2013 | VSTM | Verastem, Inc. | Westphal Christoph H | President and C.E.O ... | Buy | L | 8.77 | 124 | 1,087 | 709,693 | 709.6 K to 709.7 K (+0.02 %) |
Jan 03 2013 | VSTM | Verastem, Inc. | Westphal Christoph H | President and C.E.O ... | Buy | L | 8.72 | 100 | 872 | 709,569 | 709.5 K to 709.6 K (+0.01 %) |
Dec 20 2012 | VSTM | Verastem, Inc. | CLARKE JOHN K | Director | Buy | P | 7.87 | 6,193 | 48,739 | 2,240,319 | 2.2 M to 2.2 M (+0.28 %) |
Dec 19 2012 | VSTM | Verastem, Inc. | CHP III LP | 10% Owner | Buy | P | 7.87 | 6,193 | 48,739 | 2,240,319 | 2.2 M to 2.2 M (+0.28 %) |
Nov 27 2012 | VSTM | Verastem, Inc. | Kauffman Michael | Director | Option Exercise | A | 6.47 | 25,000 | 161,750 | 25,000 | |
Nov 02 2012 | VSTM | Verastem, Inc. | Horobin Joanna | Chief Medical Offic ... | Option Exercise | A | 7.93 | 200,000 | 1,586,000 | 200,000 | |
Nov 27 2012 | VSTM | Verastem, Inc. | LAWTON ALISON FRANCIS | Director | Option Exercise | A | 6.47 | 25,000 | 161,750 | 25,000 | |
Sep 20 2012 | VSTM | Verastem, Inc. | Westphal Christoph H | President & Chief E ... | Option Exercise | A | 9.68 | 625,000 | 6,050,000 | 625,000 | |
Sep 20 2012 | VSTM | Verastem, Inc. | Westphal Christoph H | President & Chief E ... | Grant | A | 0.00 | 206,612 | 0 | 709,469 | 502.9 K to 709.5 K (+41.09 %) |
Sep 20 2012 | VSTM | Verastem, Inc. | Phanstiel S. Louise | Director | Option Exercise | A | 9.68 | 25,000 | 242,000 | 25,000 | |
Mar 08 2012 | VSTM | Verastem, Inc. | CLARKE JOHN K | Director | Option Exercise | A | 11.10 | 12,500 | 138,750 | 12,500 | |
Mar 08 2012 | VSTM | Verastem, Inc. | Deer Management Co. LLC | Director | Option Exercise | A | 11.10 | 12,500 | 138,750 | 12,500 | |
Mar 08 2012 | VSTM | Verastem, Inc. | TERMEER HENRI A | Director | Option Exercise | A | 11.10 | 12,500 | 138,750 | 12,500 | |
Mar 08 2012 | VSTM | Verastem, Inc. | Kraus Stephen | Director | Option Exercise | A | 11.10 | 12,500 | 138,750 | 12,500 | |
Mar 08 2012 | VSTM | Verastem, Inc. | GADICKE ANSBERT | Director | Option Exercise | A | 11.10 | 12,500 | 138,750 | 12,500 | |
Feb 03 2012 | VSTM | Verastem, Inc. | ALDRICH RICHARD | Director | Option Exercise | C | 0.00 | 444,444 | 0 | 0 | |
Feb 03 2012 | VSTM | Verastem, Inc. | ALDRICH RICHARD | Director | Option Exercise | C | 0.00 | 3,500,000 | 0 | 0 | |
Feb 03 2012 | VSTM | Verastem, Inc. | ALDRICH RICHARD | Director | Option Exercise | C | 0.00 | 4,000,000 | 0 | 0 | |
Feb 03 2012 | VSTM | Verastem, Inc. | ALDRICH RICHARD | Director | Grant | A | 10.00 | 600,000 | 6,000,000 | 2,869,841 | 2.3 M to 2.9 M (+26.43 %) |
Feb 03 2012 | VSTM | Verastem, Inc. | ALDRICH RICHARD | Director | Buy | C | 0.00 | 126,984 | 0 | 2,269,841 | 2.1 M to 2.3 M (+5.93 %) |
Feb 03 2012 | VSTM | Verastem, Inc. | ALDRICH RICHARD | Director | Buy | C | 0.00 | 1,000,000 | 0 | 2,142,857 | 1.1 M to 2.1 M (+87.50 %) |
Feb 03 2012 | VSTM | Verastem, Inc. | ALDRICH RICHARD | Director | Buy | C | 0.00 | 1,142,857 | 0 | 1,142,857 | 0 to 1.1 M |
Mar 08 2012 | VSTM | Verastem, Inc. | ALDRICH RICHARD | Director | Option Exercise | A | 11.10 | 12,500 | 138,750 | 12,500 | |
Mar 08 2012 | VSTM | Verastem, Inc. | Westphal Christoph H | President and CEO | Option Exercise | A | 11.10 | 12,500 | 138,750 | 12,500 | |
Feb 03 2012 | VSTM | Verastem, Inc. | MPM BIOVENTURES V LLC | Option Exercise | C | 0.00 | 266,666 | 0 | 0 | ||
Feb 03 2012 | VSTM | Verastem, Inc. | MPM BIOVENTURES V LLC | Option Exercise | C | 0.00 | 2,500,000 | 0 | 0 | ||
Feb 03 2012 | VSTM | Verastem, Inc. | MPM BIOVENTURES V LLC | Option Exercise | C | 0.00 | 4,000,000 | 0 | 0 | ||
Feb 03 2012 | VSTM | Verastem, Inc. | MPM BIOVENTURES V LLC | Buy | P | 10.00 | 100,000 | 1,000,000 | 2,033,333 | 1.9 M to 2 M (+5.17 %) | |
Feb 03 2012 | VSTM | Verastem, Inc. | MPM BIOVENTURES V LLC | Buy | C | 0.00 | 1,933,333 | 0 | 1,933,333 | 0 to 1.9 M | |
Feb 03 2012 | VSTM | Verastem, Inc. | Bessemer Venture Partners VII ... | Director | Option Exercise | C | 0.00 | 133,333 | 0 | 0 | |
Feb 03 2012 | VSTM | Verastem, Inc. | Bessemer Venture Partners VII ... | Director | Option Exercise | C | 0.00 | 2,500,000 | 0 | 0 | |
Feb 03 2012 | VSTM | Verastem, Inc. | Bessemer Venture Partners VII ... | Director | Option Exercise | C | 0.00 | 4,000,000 | 0 | 0 | |
Feb 03 2012 | VSTM | Verastem, Inc. | Bessemer Venture Partners VII ... | Director | Buy | C | 0.00 | 38,095 | 0 | 1,995,237 | 2 M to 2 M (+1.95 %) |
Feb 03 2012 | VSTM | Verastem, Inc. | Bessemer Venture Partners VII ... | Director | Buy | C | 0.00 | 714,285 | 0 | 1,957,142 | 1.2 M to 2 M (+57.47 %) |
Feb 03 2012 | VSTM | Verastem, Inc. | Bessemer Venture Partners VII ... | Director | Buy | C | 0.00 | 1,142,857 | 0 | 1,242,857 | 100 K to 1.2 M (+1,142.86 %) |
Feb 03 2012 | VSTM | Verastem, Inc. | Bessemer Venture Partners VII ... | Director | Buy | P | 10.00 | 100,000 | 1,000,000 | 100,000 | 0 to 100 K |
Feb 03 2012 | VSTM | Verastem, Inc. | Longwood Fund, L.P. | 10% Owner | Option Exercise | C | 0.00 | 444,444 | 0 | 0 | |
Feb 03 2012 | VSTM | Verastem, Inc. | Longwood Fund, L.P. | 10% Owner | Option Exercise | C | 0.00 | 3,500,000 | 0 | 0 | |
Feb 03 2012 | VSTM | Verastem, Inc. | Longwood Fund, L.P. | 10% Owner | Option Exercise | C | 0.00 | 4,000,000 | 0 | 0 | |
Feb 03 2012 | VSTM | Verastem, Inc. | Longwood Fund, L.P. | 10% Owner | Grant | A | 10.00 | 600,000 | 6,000,000 | 2,869,841 | 2.3 M to 2.9 M (+26.43 %) |
Feb 03 2012 | VSTM | Verastem, Inc. | Longwood Fund, L.P. | 10% Owner | Buy | C | 0.00 | 126,984 | 0 | 2,269,841 | 2.1 M to 2.3 M (+5.93 %) |
Feb 03 2012 | VSTM | Verastem, Inc. | Longwood Fund, L.P. | 10% Owner | Buy | C | 0.00 | 1,000,000 | 0 | 2,142,857 | 1.1 M to 2.1 M (+87.50 %) |
Feb 03 2012 | VSTM | Verastem, Inc. | Longwood Fund, L.P. | 10% Owner | Buy | C | 0.00 | 1,142,857 | 0 | 1,142,857 | 0 to 1.1 M |
Feb 03 2012 | VSTM | Verastem, Inc. | Pachter Jonathan | VP, Head of Researc ... | Grant | A | 0.00 | 85,714 | 0 | 85,714 | 0 to 85.7 K |
Feb 03 2012 | VSTM | Verastem, Inc. | CLARKE JOHN K | Director | Option Exercise | C | 0.00 | 444,444 | 0 | 0 | |
Feb 03 2012 | VSTM | Verastem, Inc. | CLARKE JOHN K | Director | Option Exercise | C | 0.00 | 2,500,000 | 0 | 0 | |
Feb 03 2012 | VSTM | Verastem, Inc. | CLARKE JOHN K | Director | Option Exercise | C | 0.00 | 4,000,000 | 0 | 0 | |
Feb 03 2012 | VSTM | Verastem, Inc. | CLARKE JOHN K | Director | Buy | P | 10.00 | 250,000 | 2,500,000 | 2,234,126 | 2 M to 2.2 M (+12.60 %) |
Feb 03 2012 | VSTM | Verastem, Inc. | CLARKE JOHN K | Director | Buy | C | 0.00 | 126,984 | 0 | 1,984,126 | 1.9 M to 2 M (+6.84 %) |
Feb 03 2012 | VSTM | Verastem, Inc. | CLARKE JOHN K | Director | Buy | C | 0.00 | 714,285 | 0 | 1,857,142 | 1.1 M to 1.9 M (+62.50 %) |
Feb 03 2012 | VSTM | Verastem, Inc. | CLARKE JOHN K | Director | Buy | C | 0.00 | 1,142,857 | 0 | 1,142,857 | 0 to 1.1 M |
Feb 03 2012 | VSTM | Verastem, Inc. | Westphal Christoph H | President and CEO | Option Exercise | C | 0.00 | 444,444 | 0 | 0 | |
Feb 03 2012 | VSTM | Verastem, Inc. | Westphal Christoph H | President and CEO | Option Exercise | C | 0.00 | 3,500,000 | 0 | 0 | |
Feb 03 2012 | VSTM | Verastem, Inc. | Westphal Christoph H | President and CEO | Option Exercise | C | 0.00 | 4,000,000 | 0 | 0 | |
Feb 03 2012 | VSTM | Verastem, Inc. | Westphal Christoph H | President and CEO | Grant | A | 10.00 | 600,000 | 6,000,000 | 2,869,841 | 2.3 M to 2.9 M (+26.43 %) |
Feb 03 2012 | VSTM | Verastem, Inc. | Westphal Christoph H | President and CEO | Buy | C | 0.00 | 126,984 | 0 | 2,269,841 | 2.1 M to 2.3 M (+5.93 %) |
Feb 03 2012 | VSTM | Verastem, Inc. | Westphal Christoph H | President and CEO | Buy | C | 0.00 | 1,000,000 | 0 | 2,142,857 | 1.1 M to 2.1 M (+87.50 %) |
Feb 03 2012 | VSTM | Verastem, Inc. | Westphal Christoph H | President and CEO | Buy | C | 0.00 | 1,142,857 | 0 | 1,142,857 | 0 to 1.1 M |
Feb 03 2012 | VSTM | Verastem, Inc. | GADICKE ANSBERT | Director | Option Exercise | C | 0.00 | 266,666 | 0 | 0 | |
Feb 03 2012 | VSTM | Verastem, Inc. | GADICKE ANSBERT | Director | Option Exercise | C | 0.00 | 2,500,000 | 0 | 0 | |
Feb 03 2012 | VSTM | Verastem, Inc. | GADICKE ANSBERT | Director | Option Exercise | C | 0.00 | 4,000,000 | 0 | 0 | |
Feb 03 2012 | VSTM | Verastem, Inc. | GADICKE ANSBERT | Director | Buy | P | 10.00 | 3,740 | 37,400 | 3,740 | 0 to 3.7 K |
Feb 03 2012 | VSTM | Verastem, Inc. | GADICKE ANSBERT | Director | Buy | P | 10.00 | 96,260 | 962,600 | 2,029,593 | 1.9 M to 2 M (+4.98 %) |
Feb 03 2012 | VSTM | Verastem, Inc. | GADICKE ANSBERT | Director | Buy | C | 0.00 | 76,190 | 0 | 1,933,333 | 1.9 M to 1.9 M (+4.10 %) |
Feb 03 2012 | VSTM | Verastem, Inc. | GADICKE ANSBERT | Director | Buy | C | 0.00 | 714,286 | 0 | 1,857,143 | 1.1 M to 1.9 M (+62.50 %) |
Feb 03 2012 | VSTM | Verastem, Inc. | GADICKE ANSBERT | Director | Buy | C | 0.00 | 1,142,857 | 0 | 1,142,857 | 0 to 1.1 M |
Feb 03 2012 | VSTM | Verastem, Inc. | Forrester Robert | Chief Operating Off ... | Grant | A | 0.00 | 142,857 | 0 | 270,857 | 128 K to 270.9 K (+111.61 %) |
Jan 31 2012 | VSTM | Verastem, Inc. | CHP III LP | 10% Owner | Option Exercise | C | 0.00 | 444,444 | 0 | 0 | |
Jan 31 2012 | VSTM | Verastem, Inc. | CHP III LP | 10% Owner | Option Exercise | C | 0.00 | 2,500,000 | 0 | 0 | |
Jan 31 2012 | VSTM | Verastem, Inc. | CHP III LP | 10% Owner | Option Exercise | C | 0.00 | 4,000,000 | 0 | 0 | |
Jan 31 2012 | VSTM | Verastem, Inc. | CHP III LP | 10% Owner | Buy | P | 10.00 | 250,000 | 2,500,000 | 2,234,126 | 2 M to 2.2 M (+12.60 %) |
Jan 31 2012 | VSTM | Verastem, Inc. | CHP III LP | 10% Owner | Buy | C | 0.00 | 1,984,126 | 0 | 1,984,126 | 0 to 2 M |